Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 14, 2025 08:00 ET | Source: Route 92 Medical, Inc.

Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial

Route 92 Medical announced results from an independent real-world study of its HiPoint Reperfusion System and plans for a 500-patient SUMMIT RISE study.
May 21, 2025 08:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study

Route 92 Medical announces results of the SUMMIT MAX randomized clinical trial and receipt of a 510(k) clearance for the HiPoint 88 Reperfusion System.
March 27, 2025 08:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Receives Australian Therapeutic Goods Administration Approval for its Portfolio of Neurovascular Interventional Products for Treating Patients with Acute Ischemic Stroke

Route 92 Medical receives Australian Therapeutic Goods Administration approval for its portfolio of neurovascular interventional products.
March 19, 2025 09:00 ET | Source: Route 92 Medical, Inc.

First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension

First-of-its-kind multicenter study demonstrates the utility of the Monopoint system in procedures to treat idiopathic intracranial hypertension.
February 21, 2024 08:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial

Route 92 Medical announces completion of enrollment in the SUMMIT MAX clinical trial studying their .088" HiPoint Reperfusion Catheter.